NL-OMON53692招募中不适用
Positron emission tomography with innovative laboratory techniques for improved risk and disease assessment in myeloma - IMMPROVED
niversiteit Antwerpen0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Transplant eligible newly diagnosed multiple myeloma based on current IMWG
- •criteria and scheduled for induction therapy followed by autologous stam cell
- •transplantation.
- •- Baseline 18F-FDG PET/CT scan should be performed. Prior to start of
- •treatment, or within 7 days after the start. the scan should show FDG avid
- •- WHO performance status 0-2 (WHO >2 can be allowed if due to underlying
- •disease and after discussion with the physician)
- •- Age 18 years or older
- •- life expectancy > 12 months, based on clinical judgement.
- •- achieving at least VGPR after induction therapy and ASCT according to the
- •standard IMWG response criteria.
- •- received at least one (28-day) cycle of lenalidomide as maintenance therapy
- •after ASCT. No new therapy can be given until clinical relapse.
排除标准
- •- any physical or physiological condition that may affect adherence to the
- •study protocol (severe claustrophobia, inability to lie still for 30 minutes)
- •- uncontrolled diabetes
- •- history or concomitant presence of any other malignancy, except for:
- •non-melanoma skin cancer, carcinoma in situ of the cervix, any other
- •effectively treated malignancy that has been in remission for >5 years or that
- •is highly likely to be cured at time of enrollment.
- •- pregnant or breast feeding
- •- no informed consent
- •- participation in other (interventional) clinical trials without permission of
- •the study team.
研究者
相似试验
尚未招募
不适用
Positron Emission Tomography as a diagnostic tool in Unilateral Condylar Hyperplasia and comparison with bone scintigraphy, including SPECTTemporo-Mandibulaire Gewrichtgrowth of the temporo-mandibular jointUnilateral Condylar HyperplasiaNL-OMON30174Vrije Universiteit Medisch Centrum6
已完成
不适用
Positron Emission Tomography And Recovery following Revascularization: Outcomes and Cost-Effectiveness using F-18-fluorodeoxyglucose (FDG) PET in Severe Left Ventricular Dysfunction (PARR Phase 2)Coronary artery disease, LV dysfunction, congestive heart failureCirculatory SystemCoronary artery diseaseISRCTN00827330niversity of Ottawa Heart Institute (Canada)430
已完成
不适用
Imaging study using positron emission tomography with AV-45 for dementiadementiaJPRN-UMIN000003608ippon Medical School75
进行中（未招募）
1 期
PET in aggressive lymphomaAggressive non-Hodgkin's lymphomas (first line therapy)EUCTR2006-001641-33-DEniversitätsklinikum Essen696
已完成
不适用
Imaging study using positron emission tomography for the effect of nootropics on the athletic performancehealthy adultsJPRN-UMIN000004907ippon Medical School15